NYSE:DVAHealthcare
DaVita (DVA): Assessing Valuation After Revenue Beat and Lowered Profit Outlook
If you have been following DaVita (DVA) lately, you know that this week’s earnings report had something for both optimists and skeptics. The company managed to slightly exceed revenue expectations, but shares slid 3.1% during the afternoon session after markets retreated, driven in part by DaVita lowering its full-year profit guidance. Operational hurdles like declining patient count and more center closures continue to create uncertainty around growth, and investors are understandably...